Visit our USA website
Re:Cognition Health is proud to announce that we have been shortlisted as a finalist in the prestigious LaingBuisson Awards 2025, recognised in the category of Best Healthcare Outcomes.
Now in their 20th year, the LaingBuisson Awards are regarded as one of the highest accolades within the UK health and social care sector. Judged independently, the awards honour organisations that set new standards of excellence, innovation and quality, celebrating those who deliver life-changing outcomes for patients and their families.
A Global Vision for Brain and Mind Health
Re:Cognition Health was founded with a clear mission: to transform brain and mind health through early diagnosis, pioneering treatments and global education. Our multidisciplinary team of experts provides integrated care across a broad spectrum of conditions, including Alzheimer’s disease, traumatic brain injury, autism, ADHD, PTSD and long Covid.
At the heart of our approach is the belief that prevention, proactive care and access to innovation are essential to better outcomes. By bridging the gap between research and real-world treatment, we empower individuals and families with knowledge, support and access to life-changing therapies.
What Sets Us Apart
Re:Cognition Health is proud to lead the way in delivering disease-modifying treatments for Alzheimer’s disease. In January 2025, we became the first clinic in the UK and Europe to offer Kisunla (donanemab), a groundbreaking therapy targeting the underlying pathology of Alzheimer’s. Alongside Leqembi (lecanemab), also available through our clinics, these treatments represent a paradigm shift – slowing disease progression and helping preserve independence and quality of life for patients diagnosed at an early stage.
Our flagship 8,000 sq. ft Harley Street clinic, opened in 2024, brings together private care, clinical trials and medico-legal services under one roof in a state-of-the-art, patient-centred environment. Purpose-built to create calm and comfort, the clinic includes sensory-conscious design, low-stimulation suites and neurodiversity-friendly spaces for children—ensuring every individual receives tailored support.
Harnessing Innovation and Technology
Innovation runs through every aspect of our work. From pioneering diagnostic tools and cutting-edge trials to AI-powered patient engagement systems, we are reshaping the delivery of neurological care.
Our digital enrolment platform, for example, has reduced call drop-offs and saved over 20 hours per week for enrolment officers, enabling faster access to vital clinical trials across both the UK and USA.
Beyond technology, we are committed to sustainable healthcare. Working with Minimum.com since 2020, Re:Cognition Health has integrated eco-conscious design into its clinics and achieved carbon-neutral operations, aligning world-class care with environmental responsibility.
Making a Lasting Impact
Re:Cognition Health’s influence extends far beyond the clinic walls. From appearing on the BBC’s Panorama: Alzheimer’s – A Turning Point to delivering global education through TEDx talks and scientific publications, our team has been instrumental in shaping public and professional awareness of emerging therapies.
The launch of the Brain and Mind Foundation in 2024 further strengthens our global impact, supporting research, education and improved access for underserved neurological conditions.
A Recognition of Outcomes
Being shortlisted for the LaingBuisson Award for Best Healthcare Outcomes is a testament to the dedication of our clinical teams and the trust placed in us by patients and their families. It reflects our commitment to turning scientific breakthroughs into meaningful, measurable improvements in health and quality of life.
As we continue to grow in the UK, USA and beyond, our focus remains the same: to pioneer new standards of care, deliver exceptional outcomes and transform the future of brain and mind health.
